House Draft Drug Pricing Bill Offers Aggressive Policies But Near-Term Prospects Look Weak

Draft drug pricing legislation being developed under the auspices of US House Speaker Nancy Pelosi, D-CA, seeks to move aggressively to lower prescription drug prices, but key provisions are unlikely to gain traction in the Senate, which makes it look like a non-starter.

Nevertheless, Pelosi is clearly interested in staking a claim for Democrats in the drug pricing issue and her bill may be a preview of what to